ima-claude 2.15.0 → 2.16.0
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- package/README.md +4 -0
- package/dist/cli.js +14 -1
- package/package.json +1 -1
- package/plugins/ima-claude/.claude-plugin/plugin.json +2 -2
- package/plugins/ima-claude/skills/ima-copywriting/SKILL.md +232 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-blog-post.md +51 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-fundraising-email.md +54 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-newsletter.md +54 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-op-ed.md +41 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-press-release.md +45 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-social-media.md +141 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/format-webinar-email.md +37 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/ima-copy-frameworks.md +299 -0
- package/plugins/ima-claude/skills/ima-copywriting/references/ima-transitions.md +199 -0
- package/plugins/ima-claude/skills/ima-editorial-scorecard/SKILL.md +159 -0
- package/plugins/ima-claude/skills/ima-editorial-scorecard/references/format-expectations.md +66 -0
- package/plugins/ima-claude/skills/ima-editorial-scorecard/references/scoring-rubrics.md +73 -0
- package/plugins/ima-claude/skills/ima-editorial-workflow/SKILL.md +171 -0
- package/plugins/ima-claude/skills/ima-email-creator/SKILL.md +104 -0
- package/plugins/ima-claude/skills/ima-email-creator/assets/base-template.html +256 -0
- package/plugins/ima-claude/skills/ima-email-creator/references/drip-sequence.md +66 -0
- package/plugins/ima-claude/skills/ima-email-creator/references/email-css-safe.md +104 -0
- package/plugins/ima-claude/skills/ima-email-creator/references/espocrm-compat.md +58 -0
- package/plugins/ima-claude/skills/ima-email-creator/references/newsletter-layout.md +127 -0
- package/plugins/ima-claude/skills/ima-email-creator/references/wp-transactional.md +77 -0
- package/plugins/ima-claude/skills/ima-email-creator/scripts/css-inliner.py +47 -0
- package/plugins/ima-claude/skills/ima-email-creator/scripts/espocrm-prep.py +52 -0
- package/plugins/ima-claude/skills/ima-email-creator/scripts/requirements.txt +2 -0
|
@@ -0,0 +1,141 @@
|
|
|
1
|
+
# Format: Social Media Post (X/Twitter)
|
|
2
|
+
|
|
3
|
+
IMA's public-facing voice on social platforms. Substance over hype, people as the story.
|
|
4
|
+
|
|
5
|
+
## Tone
|
|
6
|
+
- **Primary:** Friendly + Informational
|
|
7
|
+
- Controlled intensity when earned (statements, action campaigns)
|
|
8
|
+
- Warm and celebratory for announcements
|
|
9
|
+
- Measured and authoritative for statements
|
|
10
|
+
- Let evidence carry research posts — don't oversell
|
|
11
|
+
|
|
12
|
+
## Content Categories
|
|
13
|
+
|
|
14
|
+
Social posts fall into seven recurring categories. Identify the category first, then follow its pattern.
|
|
15
|
+
|
|
16
|
+
### 1. Video/Research Breakdown
|
|
17
|
+
Amplify IMA-produced video content on studies or research.
|
|
18
|
+
|
|
19
|
+
```
|
|
20
|
+
[Editorial headline — frames the story, not just the study]
|
|
21
|
+
|
|
22
|
+
[Summary paragraph: names researchers, journal, IMA expert.
|
|
23
|
+
Threads 2-3 elements into a coherent narrative.]
|
|
24
|
+
|
|
25
|
+
[Video embed with IMA branding]
|
|
26
|
+
```
|
|
27
|
+
|
|
28
|
+
**Example headline style:** "When Censorship of Science Sparks a Firestorm: A COVID-Vaccine–Cancer Review and the Backlash That Followed"
|
|
29
|
+
|
|
30
|
+
### 2. Press Release/Statement
|
|
31
|
+
Distribute official IMA positions on breaking news or policy changes.
|
|
32
|
+
|
|
33
|
+
```
|
|
34
|
+
[Headline: mirrors press release headline]
|
|
35
|
+
|
|
36
|
+
FULL STATEMENT: (Washington, DC) [Full statement text.
|
|
37
|
+
Can be long-form on X. Includes IMA position,
|
|
38
|
+
Dr. Varon quote, named fellows/advisors involved,
|
|
39
|
+
broader context.]
|
|
40
|
+
|
|
41
|
+
[@tags for relevant government agencies, IMA leaders]
|
|
42
|
+
```
|
|
43
|
+
|
|
44
|
+
**Key pattern:** "FULL STATEMENT:" label signals authority and completeness.
|
|
45
|
+
|
|
46
|
+
### 3. Action/Campaign
|
|
47
|
+
Drive petition signatures, advocacy actions, or campaign participation.
|
|
48
|
+
|
|
49
|
+
```
|
|
50
|
+
[Urgency opener — earned, not manufactured]
|
|
51
|
+
[Specific ask: what to do, who to push, why now]
|
|
52
|
+
[Direct link to action page]
|
|
53
|
+
|
|
54
|
+
[Campaign graphic with clear CTA]
|
|
55
|
+
```
|
|
56
|
+
|
|
57
|
+
**Exclamation points acceptable** in campaign openers ("The time is now!").
|
|
58
|
+
|
|
59
|
+
### 4. Senior Fellow Media Hit
|
|
60
|
+
Amplify IMA fellows' appearances on external media outlets.
|
|
61
|
+
|
|
62
|
+
```
|
|
63
|
+
"[Direct quote from the fellow]" – @[fellow handle]
|
|
64
|
+
|
|
65
|
+
IMA Senior Fellow [Dr. Name] joined [host] on [outlet]
|
|
66
|
+
[this morning/today] to discuss [specific topic]. Watch now.
|
|
67
|
+
|
|
68
|
+
[Video clip from the appearance]
|
|
69
|
+
```
|
|
70
|
+
|
|
71
|
+
**Key pattern:** Open with the quote pull. It stops the scroll.
|
|
72
|
+
|
|
73
|
+
### 5. IMA News/Announcement
|
|
74
|
+
Organizational milestones — new fellows, appointments, awards, events.
|
|
75
|
+
|
|
76
|
+
```
|
|
77
|
+
[Warm announcement — "We are thrilled to announce..."]
|
|
78
|
+
|
|
79
|
+
[Branded infographic does the heavy lifting]
|
|
80
|
+
```
|
|
81
|
+
|
|
82
|
+
**Keep copy short.** The graphic carries the details (names, specialties, numbers). Copy just frames the celebration.
|
|
83
|
+
|
|
84
|
+
### 6. Journal/Article Promotion
|
|
85
|
+
Promote content from the Journal of Independent Medicine.
|
|
86
|
+
|
|
87
|
+
```
|
|
88
|
+
[Punchy headline — translates dense science into stakes]
|
|
89
|
+
|
|
90
|
+
[Summary paragraph: names the fellow/author,
|
|
91
|
+
publication venue, key concerns. Uses precise language.]
|
|
92
|
+
Watch now.
|
|
93
|
+
|
|
94
|
+
[Thread indicator if multi-part: 1/4]
|
|
95
|
+
|
|
96
|
+
[Video embed or article link]
|
|
97
|
+
```
|
|
98
|
+
|
|
99
|
+
### 7. Weekly Webinar Promotion
|
|
100
|
+
Drive live viewership or replay clicks for the IMA Weekly Show.
|
|
101
|
+
|
|
102
|
+
```
|
|
103
|
+
Live tonight! [Host name + handle] will be joined by
|
|
104
|
+
[guest name + handle] for a discussion on [specific topics,
|
|
105
|
+
listed with commas]. [Day, date at time ET].
|
|
106
|
+
Livestream right here on X!
|
|
107
|
+
|
|
108
|
+
[IMA-branded webinar graphic with speaker headshots]
|
|
109
|
+
```
|
|
110
|
+
|
|
111
|
+
**Key pattern:** "Live tonight!" + speakers + multi-clause topic list + logistics + platform callout.
|
|
112
|
+
|
|
113
|
+
## Social-Specific Rules
|
|
114
|
+
|
|
115
|
+
| Rule | Social Convention | Email/Web Convention |
|
|
116
|
+
|------|-------------------|----------------------|
|
|
117
|
+
| CTAs | "Watch now." / "Learn more and sign:" | "Watch Now »" with chevron |
|
|
118
|
+
| Exclamation points | Acceptable in openers ("Live tonight!") | One per piece max, fundraising only |
|
|
119
|
+
| Hashtags | Sparingly or not at all | N/A |
|
|
120
|
+
| @ mentions | Strategic — speakers, orgs, media outlets | N/A |
|
|
121
|
+
| Thread indicators | "1/4" for multi-part content | N/A |
|
|
122
|
+
| Sentence fragments | Acceptable ("Watch now.") | Avoid in body copy |
|
|
123
|
+
| "FULL STATEMENT:" | Labels long-form statement posts | N/A |
|
|
124
|
+
| Quote pulls | Open with direct quote for media hits | Integrated into body |
|
|
125
|
+
| Emoji in text | Minimal to none — graphics carry the visual | Heavy (emoji map) |
|
|
126
|
+
|
|
127
|
+
## Character & Length Guidance
|
|
128
|
+
|
|
129
|
+
| Category | Typical Length | Notes |
|
|
130
|
+
|----------|--------------|-------|
|
|
131
|
+
| Video/Research | 150-300 chars | Headline + summary + CTA |
|
|
132
|
+
| Statement | 500-1500 chars | Full statement, can be long-form |
|
|
133
|
+
| Action/Campaign | 200-400 chars | Short, urgent, link-forward |
|
|
134
|
+
| Media Hit | 150-250 chars | Quote + context + CTA |
|
|
135
|
+
| Announcement | 50-150 chars | Let the graphic do the work |
|
|
136
|
+
| Journal Promotion | 200-400 chars | Headline + summary, may thread |
|
|
137
|
+
| Webinar Promo | 200-400 chars | Speakers + topic + logistics |
|
|
138
|
+
|
|
139
|
+
## Published Examples
|
|
140
|
+
|
|
141
|
+
See `social-media-posts-reference.md` in project Files for full published examples with editorial annotations and engagement data.
|
|
@@ -0,0 +1,37 @@
|
|
|
1
|
+
# Format: Webinar Promotion Email
|
|
2
|
+
|
|
3
|
+
Short, punchy, curiosity-driven. Gets people to click play.
|
|
4
|
+
|
|
5
|
+
## Tone
|
|
6
|
+
- **Primary:** Friendly + Informative (higher energy than newsletters)
|
|
7
|
+
- This is a trailer, not a summary
|
|
8
|
+
- Bullet points should make the reader feel they'll miss something if they don't click
|
|
9
|
+
- Never oversell; the content should earn the attention
|
|
10
|
+
|
|
11
|
+
## Structure
|
|
12
|
+
|
|
13
|
+
```
|
|
14
|
+
"Watch Now!" (header/button)
|
|
15
|
+
|
|
16
|
+
Hook Headline (1 sentence, conversational)
|
|
17
|
+
- Question or provocative statement
|
|
18
|
+
- "What happens when ancient medicine meets the modern exam room?"
|
|
19
|
+
- "Three clinicians cut through the peptide hype and share what actually works."
|
|
20
|
+
|
|
21
|
+
Context Paragraph (3-4 sentences)
|
|
22
|
+
- Who's in the conversation
|
|
23
|
+
- Why this matters right now
|
|
24
|
+
- One line of tension or contrast
|
|
25
|
+
|
|
26
|
+
"In this episode, you'll learn:" (3 bullet points)
|
|
27
|
+
- Each bullet = specific, actionable insight
|
|
28
|
+
- Lead with what surprises, challenges, or equips
|
|
29
|
+
|
|
30
|
+
"👉 Watch/Read Now To Get the Full Story"
|
|
31
|
+
|
|
32
|
+
Nonprofit footer
|
|
33
|
+
```
|
|
34
|
+
|
|
35
|
+
## Published Examples
|
|
36
|
+
|
|
37
|
+
See `webinar-emails-reference.md` in project Files for full published examples with editorial annotations.
|
|
@@ -0,0 +1,299 @@
|
|
|
1
|
+
# IMA Copy Frameworks Reference
|
|
2
|
+
|
|
3
|
+
Headline formulas, structural templates, and section patterns — adapted for IMA's content types and mission.
|
|
4
|
+
|
|
5
|
+
---
|
|
6
|
+
|
|
7
|
+
## Headline Formulas
|
|
8
|
+
|
|
9
|
+
### Research / Study Headlines
|
|
10
|
+
|
|
11
|
+
**"New [Study Type] [Verb]: [Finding]"**
|
|
12
|
+
> Major New Study: "Measles Is Highly Treatable"
|
|
13
|
+
|
|
14
|
+
**"[Evidence Framing] — [Consequence or Irony]"**
|
|
15
|
+
> New Study Links COVID Vaccination to Cancer Signals — And the Attempt to Suppress It Backfired
|
|
16
|
+
|
|
17
|
+
**"How [Question That Implies Failure]?"**
|
|
18
|
+
> How Did Regulators Miss DNA Contamination in COVID mRNA "Vaccines"?
|
|
19
|
+
|
|
20
|
+
**"New [Study Type] Reveals [Finding] in [Condition]"**
|
|
21
|
+
> New Review Reveals Mitochondrial Dysfunction in Long COVID and PACVS
|
|
22
|
+
|
|
23
|
+
---
|
|
24
|
+
|
|
25
|
+
### Newsletter Subject Lines
|
|
26
|
+
|
|
27
|
+
**"This Week: [Item 1], [Item 2], and [Item 3 or Theme]"**
|
|
28
|
+
> This Week: 3 Studies, 1 Cyberattack, and DNA Contamination Confirmed
|
|
29
|
+
|
|
30
|
+
**"This Week: [Theme] — [Specific Payoff]"**
|
|
31
|
+
> This Week: Peptides Demystified — 3 Experts, a Webinar, and a Guide You'll Actually Use
|
|
32
|
+
|
|
33
|
+
**"This Week: [Event], [Event], and [Brand Phrase]"**
|
|
34
|
+
> This Week: NYT Attacks, HHS Appoints, and Honest Medicine Keeps Winning
|
|
35
|
+
|
|
36
|
+
---
|
|
37
|
+
|
|
38
|
+
### Webinar Headlines (Hook Lines)
|
|
39
|
+
|
|
40
|
+
**"[Question that reframes the topic]?"**
|
|
41
|
+
> What happens when ancient medicine meets the modern exam room?
|
|
42
|
+
|
|
43
|
+
**"[Number] clinicians [action] and [promise]."**
|
|
44
|
+
> Three clinicians cut through the peptide hype and share what actually works.
|
|
45
|
+
|
|
46
|
+
**"[Place/Person] proved it can be done. Now [next step]."**
|
|
47
|
+
> Idaho proved it can be done. Now the coalition is taking it nationwide.
|
|
48
|
+
|
|
49
|
+
---
|
|
50
|
+
|
|
51
|
+
### Fundraising Headlines
|
|
52
|
+
|
|
53
|
+
**"[Emotional truth without fear-mongering]."**
|
|
54
|
+
> Cancer patients need more than hope.
|
|
55
|
+
|
|
56
|
+
**"When [authority conflict], who do you trust?"**
|
|
57
|
+
> When the CDC and the AAP can't agree, who do you trust?
|
|
58
|
+
|
|
59
|
+
**"[Simple ask tied to mission]."**
|
|
60
|
+
> Share the Love: The Trusted Referral Network
|
|
61
|
+
|
|
62
|
+
---
|
|
63
|
+
|
|
64
|
+
### Op-Ed Headlines
|
|
65
|
+
|
|
66
|
+
**"[Twist on opponent's own framing]"**
|
|
67
|
+
> Rejecting Decades of Healthcare Dictates (plays on NYT's "Rejecting Decades of Science")
|
|
68
|
+
|
|
69
|
+
**"[Provocative reframing of 'offense']"**
|
|
70
|
+
> The Crime of Asking Questions
|
|
71
|
+
|
|
72
|
+
---
|
|
73
|
+
|
|
74
|
+
### Press Release Headlines
|
|
75
|
+
|
|
76
|
+
**"[Organization/Person] [Action Verb] [Newsworthy Element]"**
|
|
77
|
+
> World-Renowned Physicians and Scientific Leaders Convene in Texas this April for IMA's 5th Annual Medical Education Conference
|
|
78
|
+
|
|
79
|
+
**"[Adjective] New [Study/Finding]: '[Key Conclusion]'"**
|
|
80
|
+
> Major New Study: "Measles Is Highly Treatable"
|
|
81
|
+
|
|
82
|
+
**"[Status Quo Framing]: [What Actually Happened]"**
|
|
83
|
+
> Status Quo Fights Back: Congressional Partisans Petition HHS in Attempt to Block ACIP's Review & Discussion of 'the Science'
|
|
84
|
+
|
|
85
|
+
---
|
|
86
|
+
|
|
87
|
+
## Newsletter Section Templates
|
|
88
|
+
|
|
89
|
+
### Standard Content Block
|
|
90
|
+
|
|
91
|
+
```
|
|
92
|
+
[Emoji] [Headline — active, specific]
|
|
93
|
+
|
|
94
|
+
[2-3 sentence summary. First sentence = what happened. Second = why it matters.
|
|
95
|
+
Third (optional) = the twist, the irony, or the stakes.]
|
|
96
|
+
|
|
97
|
+
[CTA Verb] Now »
|
|
98
|
+
```
|
|
99
|
+
|
|
100
|
+
**Good example:**
|
|
101
|
+
```
|
|
102
|
+
🔬 New Study Links COVID Vaccination to Cancer Signals
|
|
103
|
+
— And the Attempt to Suppress It Backfired
|
|
104
|
+
|
|
105
|
+
A major new review published in Oncotarget examines the temporal
|
|
106
|
+
relationship between COVID-19 vaccination and cancer — and the reaction
|
|
107
|
+
to its publication tells its own story. IMA Chief Scientific Officer
|
|
108
|
+
Dr. Paul Marik breaks down the findings, the cyberattack on the journal,
|
|
109
|
+
and what it all means.
|
|
110
|
+
|
|
111
|
+
Watch Now »
|
|
112
|
+
```
|
|
113
|
+
|
|
114
|
+
### Conference Promotion Block
|
|
115
|
+
|
|
116
|
+
```
|
|
117
|
+
IMA [Year] [Event Name] — [Urgency if applicable]!
|
|
118
|
+
|
|
119
|
+
[1-2 sentences: what, when, where.]
|
|
120
|
+
[What makes it valuable: CME credits, speakers, hands-on learning.]
|
|
121
|
+
|
|
122
|
+
🎟 Buy Tickets Now »
|
|
123
|
+
```
|
|
124
|
+
|
|
125
|
+
### Support Block (Newsletter Footer)
|
|
126
|
+
|
|
127
|
+
```
|
|
128
|
+
PLEASE SUPPORT HONEST MEDICINE
|
|
129
|
+
|
|
130
|
+
[Concrete inventory of this week's output.] This is what independent
|
|
131
|
+
medicine looks like [variation]. [No pharma variation.]
|
|
132
|
+
|
|
133
|
+
If you've found value in what we do, your support helps us keep going.
|
|
134
|
+
|
|
135
|
+
Please Support IMA's Mission »
|
|
136
|
+
```
|
|
137
|
+
|
|
138
|
+
---
|
|
139
|
+
|
|
140
|
+
## Fundraising Email Templates
|
|
141
|
+
|
|
142
|
+
### Match Campaign Structure
|
|
143
|
+
|
|
144
|
+
```
|
|
145
|
+
[Emotional headline]
|
|
146
|
+
[Donate CTA button]
|
|
147
|
+
EVERY DOLLAR DOUBLED[!]
|
|
148
|
+
|
|
149
|
+
[Pull quote — attributed to campaign leader]
|
|
150
|
+
|
|
151
|
+
Dear {Person.name},
|
|
152
|
+
|
|
153
|
+
[Problem — 2-3 sentences, personal and specific]
|
|
154
|
+
[Pivot to IMA's response — 1-2 sentences]
|
|
155
|
+
[Match mechanic — "right now, your gift will go twice as far"]
|
|
156
|
+
|
|
157
|
+
Why Your Support Matters
|
|
158
|
+
[3-4 bullet points: urgency + specificity]
|
|
159
|
+
|
|
160
|
+
💙 Match My Gift Today »
|
|
161
|
+
|
|
162
|
+
Your Gift Powers What's Next
|
|
163
|
+
[4 bullet points: what the money funds]
|
|
164
|
+
[Dollar-to-impact mapping if available]
|
|
165
|
+
|
|
166
|
+
[Signoff — name, title, full credentials]
|
|
167
|
+
|
|
168
|
+
P.S. [Match deadline reminder + bonus incentive + CTA]
|
|
169
|
+
|
|
170
|
+
🌱 [Soft CTA variation] »
|
|
171
|
+
```
|
|
172
|
+
|
|
173
|
+
### Non-Match Campaign Structure
|
|
174
|
+
|
|
175
|
+
```
|
|
176
|
+
[Mission-driven headline]
|
|
177
|
+
[Donate CTA]
|
|
178
|
+
|
|
179
|
+
Dear {Person.firstName},
|
|
180
|
+
|
|
181
|
+
[Story or problem setup — 2-3 paragraphs]
|
|
182
|
+
[What IMA is building and why it matters]
|
|
183
|
+
[The gap the donor fills]
|
|
184
|
+
|
|
185
|
+
[Specifics: what donations fund]
|
|
186
|
+
[Video embed or resource link if available]
|
|
187
|
+
|
|
188
|
+
💙 [Donate CTA] »
|
|
189
|
+
|
|
190
|
+
[Brief signoff]
|
|
191
|
+
```
|
|
192
|
+
|
|
193
|
+
---
|
|
194
|
+
|
|
195
|
+
## Press Release Template
|
|
196
|
+
|
|
197
|
+
```
|
|
198
|
+
FOR IMMEDIATE RELEASE
|
|
199
|
+
[Day], [Month] [DD], [YYYY]
|
|
200
|
+
[Media Contact line]
|
|
201
|
+
|
|
202
|
+
[HEADLINE IN TITLE CASE]
|
|
203
|
+
[Subheadline — additional context, italicized]
|
|
204
|
+
|
|
205
|
+
([City], [State]) — The Independent Medical Alliance [(IMA)] — a
|
|
206
|
+
[coalition/national coalition] of independent [doctors/physicians],
|
|
207
|
+
healthcare providers, and researchers — today [action verb] [what happened].
|
|
208
|
+
|
|
209
|
+
[Context paragraph: the external event, policy, publication, or
|
|
210
|
+
development that prompted this release.]
|
|
211
|
+
|
|
212
|
+
"[Quote paragraph 1 — the principle at stake]," said Dr. [Name],
|
|
213
|
+
[Title] of the Independent Medical Alliance. "[Quote paragraph 2 —
|
|
214
|
+
the evidence or logical argument]."
|
|
215
|
+
|
|
216
|
+
"[Quote paragraph 3 — the consequence of not acting / the way forward],"
|
|
217
|
+
[continued/concluded] Dr. [Name].
|
|
218
|
+
|
|
219
|
+
[Additional supporting details, data, or context. 1-3 paragraphs.]
|
|
220
|
+
|
|
221
|
+
[Additional quotes from other IMA voices if relevant.]
|
|
222
|
+
|
|
223
|
+
About [Speaker Name]
|
|
224
|
+
[1-2 sentence bio emphasizing credentials and achievements.]
|
|
225
|
+
|
|
226
|
+
About the Independent Medical Alliance (IMA)
|
|
227
|
+
[Standard boilerplate — update as organization evolves.]
|
|
228
|
+
|
|
229
|
+
Media Contact [email]
|
|
230
|
+
|
|
231
|
+
###
|
|
232
|
+
```
|
|
233
|
+
|
|
234
|
+
---
|
|
235
|
+
|
|
236
|
+
## Webinar Email Template
|
|
237
|
+
|
|
238
|
+
```
|
|
239
|
+
Watch Now!
|
|
240
|
+
|
|
241
|
+
[Hook headline — question or provocative statement]
|
|
242
|
+
|
|
243
|
+
[Context paragraph: who, what, why now. 3-4 sentences.
|
|
244
|
+
Include one line of tension or contrast.]
|
|
245
|
+
|
|
246
|
+
In this episode, you'll learn:
|
|
247
|
+
[Bullet 1: Surprising finding or reversal]
|
|
248
|
+
[Bullet 2: Practical rule or framework]
|
|
249
|
+
[Bullet 3: Systemic insight or call to awareness]
|
|
250
|
+
|
|
251
|
+
👉 Watch/Read Now To Get the Full Story
|
|
252
|
+
|
|
253
|
+
[Nonprofit footer]
|
|
254
|
+
```
|
|
255
|
+
|
|
256
|
+
---
|
|
257
|
+
|
|
258
|
+
## Section Writing Tips
|
|
259
|
+
|
|
260
|
+
### Problem Setup (Fundraising, Blog)
|
|
261
|
+
|
|
262
|
+
For IMA, problem sections should:
|
|
263
|
+
- Be specific (name the disease, the policy, the institution)
|
|
264
|
+
- Cite a real statistic or event
|
|
265
|
+
- Pivot to solution within 2-3 sentences
|
|
266
|
+
|
|
267
|
+
**Pattern:** "[Problem statement]. [Evidence of scale/urgency]. At IMA, [what we're doing]."
|
|
268
|
+
|
|
269
|
+
### Evidence Presentation (Blog, Press Release)
|
|
270
|
+
|
|
271
|
+
For each study or finding:
|
|
272
|
+
1. **What was published**: Journal name, authors, study type
|
|
273
|
+
2. **Key finding**: One sentence, plain language
|
|
274
|
+
3. **Why it matters**: Clinical or policy implication
|
|
275
|
+
4. **Where to find it**: Link or citation
|
|
276
|
+
|
|
277
|
+
### Bullet Point Discipline
|
|
278
|
+
|
|
279
|
+
IMA uses bullet points in:
|
|
280
|
+
- Quick Links blocks (emoji + title)
|
|
281
|
+
- "In this episode, you'll learn" (webinar emails)
|
|
282
|
+
- "Your Gift Powers What's Next" (fundraising)
|
|
283
|
+
- Key takeaways (press releases, blog posts)
|
|
284
|
+
|
|
285
|
+
IMA does NOT use bullet points for:
|
|
286
|
+
- Body copy in newsletters or op-eds (use prose)
|
|
287
|
+
- Press release narrative sections
|
|
288
|
+
- Opening hooks
|
|
289
|
+
|
|
290
|
+
### Quote Selection
|
|
291
|
+
|
|
292
|
+
IMA quotes should:
|
|
293
|
+
- Come from a named, credentialed individual
|
|
294
|
+
- Advance an argument (not just endorse)
|
|
295
|
+
- Be quotable in isolation (for media pickup)
|
|
296
|
+
- Include title + organization on first reference
|
|
297
|
+
|
|
298
|
+
**Good quote pattern:**
|
|
299
|
+
"[Principle statement]," said Dr. [Name], [Title] of the Independent Medical Alliance. "[Evidence or logical extension]."
|
|
@@ -0,0 +1,199 @@
|
|
|
1
|
+
# IMA Transitions & Connective Phrases
|
|
2
|
+
|
|
3
|
+
Transitional phrases tuned for IMA's editorial voice. Organized by function.
|
|
4
|
+
|
|
5
|
+
Adapted from IMA's published content patterns and the University of Manchester Academic Phrasebank.
|
|
6
|
+
|
|
7
|
+
---
|
|
8
|
+
|
|
9
|
+
## Setting the Stage (Newsletter Openers, Blog Intros)
|
|
10
|
+
|
|
11
|
+
Use to orient readers and signal what's coming:
|
|
12
|
+
|
|
13
|
+
- Here's what's new in Honest Medicine.
|
|
14
|
+
- This week brought [number] studies, [event], and [development].
|
|
15
|
+
- Also this week: [quick preview of secondary items].
|
|
16
|
+
- Let's break this down.
|
|
17
|
+
- Here's the short version.
|
|
18
|
+
- Here's what we've been working on.
|
|
19
|
+
|
|
20
|
+
---
|
|
21
|
+
|
|
22
|
+
## Signaling Importance
|
|
23
|
+
|
|
24
|
+
- Here's why that matters.
|
|
25
|
+
- This is significant because...
|
|
26
|
+
- The takeaway?
|
|
27
|
+
- Here's the key finding:
|
|
28
|
+
- Pay attention to this:
|
|
29
|
+
- That distinction matters.
|
|
30
|
+
- This changes the conversation.
|
|
31
|
+
|
|
32
|
+
---
|
|
33
|
+
|
|
34
|
+
## Introducing Evidence
|
|
35
|
+
|
|
36
|
+
### Neutral attribution
|
|
37
|
+
- A new peer-reviewed study published in [Journal] found...
|
|
38
|
+
- Research from [Author/Institution] shows...
|
|
39
|
+
- According to a [year] review published in [Journal],...
|
|
40
|
+
- New data from [source] indicates...
|
|
41
|
+
- A [type] study examining [N] participants found...
|
|
42
|
+
|
|
43
|
+
### IMA researcher attribution
|
|
44
|
+
- IMA Chief Scientific Officer Dr. Paul Marik breaks down the findings.
|
|
45
|
+
- IMA researchers have proposed...
|
|
46
|
+
- IMA Senior Fellow Dr. [Name] has published...
|
|
47
|
+
- IMA President Dr. Joseph Varon responds.
|
|
48
|
+
|
|
49
|
+
### Supporting claims
|
|
50
|
+
- The evidence is consistent:
|
|
51
|
+
- Multiple studies have confirmed...
|
|
52
|
+
- This aligns with earlier findings from...
|
|
53
|
+
- The data tells a clear story:
|
|
54
|
+
|
|
55
|
+
---
|
|
56
|
+
|
|
57
|
+
## Contrast & Pushback
|
|
58
|
+
|
|
59
|
+
Use when addressing opposing claims, media attacks, or institutional positions:
|
|
60
|
+
|
|
61
|
+
- But the science isn't always keeping up with the marketing.
|
|
62
|
+
- That's not what the data shows.
|
|
63
|
+
- The reality is more nuanced.
|
|
64
|
+
- The implication is clear:
|
|
65
|
+
- Here's what they're not saying:
|
|
66
|
+
- Meanwhile,...
|
|
67
|
+
- Yet this modest position was enough to trigger...
|
|
68
|
+
- One imagines this context might be relevant.
|
|
69
|
+
- But pay no attention to [the funding/the conflict/the timing].
|
|
70
|
+
|
|
71
|
+
---
|
|
72
|
+
|
|
73
|
+
## Connecting Sections (Blog Posts, Long-Form)
|
|
74
|
+
|
|
75
|
+
- With that covered, here's what it means in practice.
|
|
76
|
+
- Now let's look at the clinical picture.
|
|
77
|
+
- That brings us to the real question:
|
|
78
|
+
- The next piece of the puzzle:
|
|
79
|
+
- Building on that,...
|
|
80
|
+
- So what does this mean for patients?
|
|
81
|
+
- Here's where it gets interesting.
|
|
82
|
+
- The practical implications:
|
|
83
|
+
|
|
84
|
+
---
|
|
85
|
+
|
|
86
|
+
## Showing Cause and Effect
|
|
87
|
+
|
|
88
|
+
- This means...
|
|
89
|
+
- As a result,...
|
|
90
|
+
- That's why...
|
|
91
|
+
- The outcome?
|
|
92
|
+
- Here's what happens when...
|
|
93
|
+
- The consequence is predictable:
|
|
94
|
+
- So,...
|
|
95
|
+
|
|
96
|
+
---
|
|
97
|
+
|
|
98
|
+
## Addition & Expansion
|
|
99
|
+
|
|
100
|
+
- Also this week:
|
|
101
|
+
- Plus,...
|
|
102
|
+
- On top of that,...
|
|
103
|
+
- There's more:
|
|
104
|
+
- Beyond that,...
|
|
105
|
+
- And it doesn't stop there.
|
|
106
|
+
- What's more,...
|
|
107
|
+
|
|
108
|
+
**Avoid overusing**: "Moreover" and "Furthermore" — they read as AI-generated when stacked.
|
|
109
|
+
|
|
110
|
+
---
|
|
111
|
+
|
|
112
|
+
## Concession Before Counterpoint
|
|
113
|
+
|
|
114
|
+
- To be clear, [acknowledged truth]. [But/However]...
|
|
115
|
+
- This isn't about [mischaracterization]. It's about [real issue].
|
|
116
|
+
- No one is arguing [straw man]. The question is [real question].
|
|
117
|
+
- [Acknowledged position] — but that's not the whole picture.
|
|
118
|
+
|
|
119
|
+
---
|
|
120
|
+
|
|
121
|
+
## Question-Based Transitions
|
|
122
|
+
|
|
123
|
+
Useful for conversational tone and creating forward momentum:
|
|
124
|
+
|
|
125
|
+
- But why does this matter?
|
|
126
|
+
- So what can you actually do about it?
|
|
127
|
+
- What's the catch?
|
|
128
|
+
- Sound complicated? It's not.
|
|
129
|
+
- Wondering where to start?
|
|
130
|
+
- What does this mean for you?
|
|
131
|
+
- Ready to take the next step?
|
|
132
|
+
|
|
133
|
+
---
|
|
134
|
+
|
|
135
|
+
## Urgency (Fundraising, Campaign, Event)
|
|
136
|
+
|
|
137
|
+
- Right now,...
|
|
138
|
+
- The situation could not be more urgent.
|
|
139
|
+
- This match won't last forever.
|
|
140
|
+
- Now is a great time to give:
|
|
141
|
+
- We can't meet it without you.
|
|
142
|
+
- Your gift today goes directly toward...
|
|
143
|
+
- With your matched donation, we will:
|
|
144
|
+
|
|
145
|
+
---
|
|
146
|
+
|
|
147
|
+
## Closing / Wrapping Up
|
|
148
|
+
|
|
149
|
+
### Newsletter close
|
|
150
|
+
- If you've found value in what we do, your support helps us keep going.
|
|
151
|
+
- This is what independent medicine looks like.
|
|
152
|
+
- No pharma funding, no institutional strings.
|
|
153
|
+
|
|
154
|
+
### Blog/article close
|
|
155
|
+
- The full study is available in [Journal].
|
|
156
|
+
- Here's what to do next:
|
|
157
|
+
- For patients and practitioners seeking guidance,...
|
|
158
|
+
|
|
159
|
+
### Fundraising close
|
|
160
|
+
- With gratitude,
|
|
161
|
+
- Thank you for standing with us.
|
|
162
|
+
- I hope to see you there.
|
|
163
|
+
|
|
164
|
+
---
|
|
165
|
+
|
|
166
|
+
## Transitions to Avoid (AI Tells)
|
|
167
|
+
|
|
168
|
+
These phrases signal AI-generated content and erode trust. Never use them:
|
|
169
|
+
|
|
170
|
+
| ❌ Avoid | Why |
|
|
171
|
+
|----------|-----|
|
|
172
|
+
| "In today's rapidly evolving healthcare landscape..." | Overused AI opener |
|
|
173
|
+
| "It's worth noting that..." | Filler; just note it |
|
|
174
|
+
| "At its core,..." | Vague intensifier |
|
|
175
|
+
| "Let's delve into..." | AI tell, overly formal |
|
|
176
|
+
| "This begs the question..." | Misused phrase + AI tell |
|
|
177
|
+
| "In conclusion,..." | Signals lazy structure |
|
|
178
|
+
| "Moreover,..." (repeated) | AI stacking pattern |
|
|
179
|
+
| "When it comes to the realm of..." | Bloated phrasing |
|
|
180
|
+
| "That being said,..." | AI hedge pattern |
|
|
181
|
+
| "Navigating the complexities of..." | Empty corporate speak |
|
|
182
|
+
| "It is important to note that..." | Just note it directly |
|
|
183
|
+
| "In light of recent developments..." | Vague temporal reference |
|
|
184
|
+
|
|
185
|
+
---
|
|
186
|
+
|
|
187
|
+
## IMA Signature Phrases
|
|
188
|
+
|
|
189
|
+
Phrases that appear across IMA content and define the editorial voice:
|
|
190
|
+
|
|
191
|
+
- "Honest Medicine" — IMA's tagline; use as a proper noun
|
|
192
|
+
- "funded by people, not pharma"
|
|
193
|
+
- "independent, evidence-based"
|
|
194
|
+
- "patient-centered care"
|
|
195
|
+
- "informed consent"
|
|
196
|
+
- "the exam room, not the federal register"
|
|
197
|
+
- "independent medicine"
|
|
198
|
+
- "Your support makes [specific outcome] possible"
|
|
199
|
+
- "You make our critical work possible."
|